1607 Capital Partners’s BlackRock Health Sciences Trust BME Stock Holding History

1607 Capital Partners’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.02M	Sell	163,553 -69,707	-30%	-$2.77M	0.61%	42
2026 Q1	$8.98M	Buy	233,260 +4,000	+2%	+$165K	0.65%	35
2025 Q4	$9.43M	Buy	229,260 +75,958	+50%	+$3M	0.64%	37
2025 Q3	$5.71M	Sell	153,302 -200	-0.1%	-$7.27K	0.43%	55
2025 Q2	$5.6M	Buy	153,502 +12,393	+9%	+$449K	0.45%	56
2025 Q1	$5.45M	Sell	141,109 -34,903	-20%	-$1.38M	0.44%	55
2024 Q4	$6.68M	Sell	176,012 -89,302	-34%	-$3.57M	0.54%	51
2024 Q3	$11.1M	Buy	265,314 +37,520	+16%	+$1.56M	1.02%	33
2024 Q2	$9.31M	Buy	227,794 +104,317	+84%	+$4.15M	0.83%	39
2024 Q1	$5.12M	Sell	123,477 -48,265	-28%	-$2.02M	0.42%	65
2023 Q4	$6.95M	Buy	171,742 +83,650	+95%	+$3.19M	0.49%	59
2023 Q3	$3.45M	Buy	+88,092	New	+$3.51M	0.26%	88
2018 Q2	–	Sell	-13,405	Closed	-$469K	–	107
2018 Q1	$469K	Buy	+13,405	New	+$477K	0.03%	109

Other funds holding BME

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

1607 Capital Partners's BME Position: Q2 2026 in Review

1607 Capital Partners reduced its BlackRock Health Sciences Trust (BME) stake by 30% in Q2 2026, selling an estimated $2.77M and leaving 163,553 shares worth $7.02M. The position accounts for 0.61% of the portfolio, ranked #42.

1607 Capital Partners first reported a position in BME in Q1 2018 and has held it in 13 quarters since. The position peaked at $11.1M in Q3 2024. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

1607 Capital Partners held 163,553 shares of BlackRock Health Sciences Trust worth $7.02M as of Q2 2026.
1607 Capital Partners sold 69,707 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $2.77M.
BlackRock Health Sciences Trust made up 0.61% of 1607 Capital Partners's portfolio in Q2 2026, its #42 holding.
1607 Capital Partners first reported a position in BlackRock Health Sciences Trust in Q1 2018 and has held it in 13 quarters since.
1607 Capital Partners's BlackRock Health Sciences Trust position peaked at $11.1M in Q3 2024.
78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on 1607 Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.